Open Your FREE Demat Account Now!

N/A
indicator

Nifty500 Healthcare Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty500 Healthcare Index Performance

Low

₹22,321.80

High

₹22,589.25

52 Week Range

Low

₹17,164.05

High

₹22,889.70

Previous Close ₹22,466.65
Day's Range ₹22,321.80 - ₹22,589.25
Open ₹22,461.65
52 Week Range ₹17,164.05 - ₹22,889.70
Volume 2,01,49,263

Nifty500 Healthcare Index Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1418.50 Arrow 1.50 (0.11%) Healthcare
Dr. Reddy's Laboratories Ltd. 1397.70 Arrow -0.50 (-0.04%) Healthcare
Lupin Ltd. 1990.10 Arrow 18.20 (0.92%) Healthcare
Torrent Pharmaceuticals Ltd. 4628.00 Arrow 17.30 (0.38%) Healthcare
Abbott India Ltd. 25715.00 Arrow 245.00 (0.96%) Healthcare
Glaxosmithkline Pharmaceuticals Ltd. 2711.20 Arrow 73.00 (2.77%) Healthcare
Apollo Hospitals Enterprise Ltd. 8738.00 Arrow -83.00 (-0.94%) Healthcare
Ipca Laboratories Ltd. 1859.90 Arrow 5.80 (0.31%) Healthcare
Neuland Laboratories Ltd. 21100.00 Arrow -355.00 (-1.65%) Healthcare
Sun Pharmaceutical Industries Ltd. 1910.00 Arrow 38.50 (2.06%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 25503.7 26373.20 22179.90
Nifty IT 30914.15 40301.40 25699.10
Nifty Next 50 72849.0 75000.40 59896.10
NIFTY50 USD Index 9475.1 10443.40 7839.85
Nifty Bank 63022.65 62442.20 49954.85
NIFTY Midcap 100 61576.9 64450.90 52032.85
Nifty 500 23887.35 24144.20 20385.65
Nifty Midcap 50 17742.55 18500.95 14804.55
Nifty 100 26387.2 26975.15 22720.45
Nifty FMCG 48529.35 55863.25 42006.00

Latest News

Nov
18
2026
EQUITY Posted on Nov 18th 2026

Ajanta Pharma informs about disclosure

Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Aurobindo Pharma submits notice of postal ballot

Aurobindo Pharma has informed that it enclosed a copy of the Postal Ballot Notice dated November 4, 2026 together with the Explanatory Statement thereto, seeking approval of the Members for: Reappointment of Mangalam Ramasubramanian Kumar (DIN: 03628755), as an Independent Director of the Company not liable to retire by rotation, for a second term of 5 (Five) consecutive years commencing from April 1, 2027 to March 31, 2032; Revision of remuneration of K. Nithyananda Reddy (DIN: 01284195), Vice Chairman & Managing Director of the Company; Revision of remuneration of Dr. M. Madan Mohan Reddy (DIN: 01284266), Whole-time Director of the Company; Revision in the commission payable to the independent directors of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Alkem Laboratories informs about earnings call transcript

Alkem Laboratories has informed that it enclosed transcript of 'Q2 & H1FY2027 Earnings Conference Call' which was hosted by the Company on Thursday, 12th November, 2026. The said transcript shall also be made available on the website of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
18
2026
EQUITY Posted on Nov 18th 2026

Biocon informs about press release

Biocon has informed that it enclosed the press release titled ‘Biocon’s Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
17
2026
EQUITY Posted on Nov 17th 2026

GlaxoSmithKline Pharmaceuticals informs about postal ballot notice

GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of Postal Ballot Notice pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which is being sent to the Members of the Company seeking their approval for Related Party Transactions with GSK Biological S.A. (Belgium). In compliance with the Circulars of the Ministry of Corporate Affairs, the said Notice is being sent electronically only to those Members, whose names appear in the Register of Members/ List of Beneficial Owners as received from National Securities Depository (‘NSDL’)/ Central Depository Services (India) (‘CDSL’) and who have registered their e-mail addresses in respect of electronic holdings with NSDL/CDSL through the concerned Depository Participants and in respect of physical holdings with the Company’s Registrar and Share Transfer Agent (RTA) - KFin Technologies as on Friday, 13th November 2026 (cut-off date). The e-voting shall commence on Wednesday, 18th November, 2026 and ends at 05.00 PM (IST) on Thursday, 17th December, 2026. The copy of the said Notice is also available on the website of the Company at https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ and on the website of Kfintech https://evoting.kfintech.com/.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NFT500HEALTH index?

The previous close of NFT500HEALTH index is ₹22581.75 as of 2026-11-19.

The total volume of NFT500HEALTH index is 20149263.00 as of 2026-11-19.

The percentage change in value of NFT500HEALTH index is 0.51% as of 2026-11-19.

The absolute increase in NFT500HEALTH index value since the previous trading day is ₹115.1 as of 2026-11-19.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More

People Also Ask

What defines the Nifty 500 Healthcare Index?

The Nifty 500 Healthcare Index is a sectoral index that tracks selected healthcare companies from the Nifty 500 universe. It represents listed businesses across healthcare delivery, pharmaceuticals, diagnostics, biotechnology, medical services, and related segments.

Companies are selected from healthcare-sector stocks within the Nifty 500 universe based on NSE Indices' methodology and industry classification. The index is reviewed periodically in accordance with the index maintenance methodology.

The Nifty 500 Healthcare Index is calculated using the free-float market capitalisation method. This approach considers only publicly available shares while assigning weights to eligible healthcare companies within the index.

The Nifty 500 Healthcare Index includes companies from pharmaceuticals, hospitals, diagnostics, biotechnology, healthcare services, medical equipment, and related healthcare businesses listed within the broader Nifty 500 universe.

Yes, hospitals, diagnostics, and pharmaceutical companies may be part of the Nifty 500 Healthcare Index if they meet the index provider’s eligibility rules. The index is designed to capture different areas of India’s healthcare sector.

The Nifty 500 Healthcare Index measures the performance of healthcare-sector companies included in the Nifty 500 universe. It reflects the market performance of listed companies engaged in areas such as pharmaceuticals, hospitals, diagnostics, biotechnology, medical equipment, and other healthcare-related businesses.

The Nifty 500 Healthcare Index is reviewed and rebalanced periodically in accordance with NSE Indices' index maintenance methodology. The review helps ensure that the index continues to reflect eligible healthcare companies within the Nifty 500 universe.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore